https://www.aigom.it/wp-content/uploads/2024/01/ARTICOLO-1801.jpg821581Alessia Losihttps://www.aigom.it/wp-content/uploads/2022/12/logo-sito.pngAlessia Losi2024-01-18 14:53:452024-01-18 14:53:45CARDIOVASCULAR DISEASE IN TESTICULAR CANCER SURVIVORS: IDENTIFICATION OF RISK FACTORS AND IMPACT ON QUALITY OF LIFE.
https://www.aigom.it/wp-content/uploads/2023/12/MONARCH-3.jpg821581Alessia Losihttps://www.aigom.it/wp-content/uploads/2022/12/logo-sito.pngAlessia Losi2023-12-21 10:43:542023-12-21 10:44:14MONARCH 3: Risultati dell’analisi finale della sopravvivenza globale presentati al San Antonio Breast Cancer Symposium (SABCS) il 6 dicembre 2023.
https://www.aigom.it/wp-content/uploads/2023/12/GAZZETTA.png7931052Alessia Losihttps://www.aigom.it/wp-content/uploads/2022/12/logo-sito.pngAlessia Losi2023-12-21 09:50:372023-12-21 09:52:14Gazzetta Ufficiale 20 dicembre 2023 n.296
https://www.aigom.it/wp-content/uploads/2023/12/met-gennaio.jpg7931052Alessia Losihttps://www.aigom.it/wp-content/uploads/2022/12/logo-sito.pngAlessia Losi2023-12-20 11:16:212024-01-29 09:52:47VENERDÌ 26 – SABATO 27 GENNAIO 2024 NEGRAR DI VALPOLICELLA (VR) | SCUOLA DI METODOLOGIA DELLA RICERCA CLINICA
https://www.aigom.it/wp-content/uploads/2023/11/METODOLOGIA-VERDE-PV.jpg7931052Alessia Losihttps://www.aigom.it/wp-content/uploads/2022/12/logo-sito.pngAlessia Losi2023-12-18 14:59:152023-12-21 11:23:321° Evento Alumni della Scuola
https://www.aigom.it/wp-content/uploads/2023/12/13dic-pr_aigom.jpg7931052Alessia Losihttps://www.aigom.it/wp-content/uploads/2022/12/logo-sito.pngAlessia Losi2023-12-15 15:01:032023-12-15 15:01:5713 dicembre 2023 | AGENAS ha presentato gli Esiti della Quinta Indagine Nazionale sullo stato di attuazione delle Reti Oncologiche Regionali
https://www.aigom.it/wp-content/uploads/2023/12/WE-BRCA-BREASY.jpg7931052Alessia Losihttps://www.aigom.it/wp-content/uploads/2022/12/logo-sito.pngAlessia Losi2023-12-04 10:32:202023-12-04 10:34:16WE BRCA BREAST | AIGOM ha dato il patrocinio a questo importante incontro scientifico
https://www.aigom.it/wp-content/uploads/2023/12/MAINTAIN-TRIAL.jpg821581Alessia Losihttps://www.aigom.it/wp-content/uploads/2022/12/logo-sito.pngAlessia Losi2023-12-04 10:20:012023-12-04 10:21:34Randomized Phase II Trial of Endocrine Therapy With or Without Ribociclib After Progression on Cyclin-Dependent Kinase 4/6 Inhibition in Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer: MAINTAIN Trial.
